LUPIN — Lupin Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Lupin, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	164,055	166,417	200,108	227,079	279,580
Cost of Revenue
Gross Profit	89,194	89,387	123,756	147,964	206,316
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	177,995	157,600	174,029	185,761	217,319
Operating Profit	-13,940	8,817	26,079	41,318	62,261
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-13,722	7,165	24,223	40,150	68,726
Provision for Income Taxes
Net Income After Taxes	-15,094	4,477	19,356	33,063	53,555
Minority Interest
Net Income Before Extraordinary Items
Net Income	-15,280	4,301	19,145	32,816	53,328
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-15,280	4,301	19,145	32,816	53,328
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.26	9.66	45.4	73.2	126
Dividends per Share